Skybound Venture Capital

Skybound Capital is a global alternative investment manager and venture capital firm with a significant focus on the life sciences and biotechnology sectors. The firm provides strategic capital and advisory services to early and growth-stage companies, identifying disruptive technologies with the potential for high impact. Skybound is notably recognized as a major institutional investor in clinical-stage biopharmaceutical companies, such as Aptorum Group, which develops therapies for orphan diseases and infectious conditions. Operating from key financial hubs including London and Hong Kong, the firm manages a diverse portfolio of private equity and venture capital investments across global markets.